The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Poor P50 Suppression Among Schizophrenia Patients and Their First-Degree Biological Relatives
Abstract
OBJECTIVE: This study's goal was to replicate the finding that family members of schizophrenia patients show poor P50 suppression during a paired-click auditory evoked response paradigm. METHOD: The paired-click paradigm was used to test 44 schizophrenia patients, 60 of their clinically unaffected first-degree relatives, and 45 normal subjects. Two clicks (83 dB[A] over a 60-dB[A] white noise background) separated by 500 msec were presented 60 times to all subjects. P50 responses to the first and second clicks were selected from the digitally filtered data by using standard methods and the Cz recording site. RESULTS: The schizophrenia patients had smaller P50 responses to click 1 than either their relatives or the normal subjects; the patients and their relatives, who did not significantly differ, had larger P50 responses to click 2 than the normal subjects. Schizophrenia patients had worse P50 suppression than either their family members or the normal subjects; the patients' family members had worse P50 suppression than the normal subjects. CONCLUSIONS: Family members of schizophrenia patients have worse P50 suppression than normal subjects. To the authors' knowledge, this is the first demonstration independent of the group associated with the University of Colorado that schizophrenia patients' family members have poor P50 suppression. This result is intrinsically important, perhaps especially because a recent report suggests genetic linkage of poor P50 suppression to the cholinergic receptor's alpha7 nicotinic subunit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sensorimotor Gating and Schizophrenia: Human and Animal Model Studies
Braff, D. L. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810140081011 · Cited by 1,309
Self-citationSchizophrenia: The epigenetic puzzle
Haier, R. J. (1982) · Psychiatry Research · doi:10.1016/0165-1781(92)90099-o · Cited by 1,167
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141
Kendler, K. S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820190029004 · Cited by 719
Freedman, R., Adler, L. E., Waldo, M. C., Pachtman, E., & Rd, F. (1983) · PubMed · Cited by 472
Neurobiological studies of sensory gating in schizophrenia
Freedman, R., Adler, L. E., Gerhardt, G. A., Waldo, M., Baker, N., Rose, G. M., Drebing, C., Nagamoto, H., Bickford-Wimer, P., & Franks, R. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.4.669 · Cited by 430
Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics
Adler, L. E., Hoffer, L. J., Griffith, J., Waldo, M. C., & Freedman, R. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90073-9 · Cited by 412
Siegel, C. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790170081009 · Cited by 382
Sensory gating deficits in schizophrenia: new results
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.4.488 · Cited by 263
Sensory gating in schizophrenics and normal controls: Effects of changing stimulation interval
Nagamoto, H. T., Adler, L. E., Waldo, M. C., & Freedman, R. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90215-1 · Cited by 257
Cited by
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
Gottesman, I. I., & Gould, T. D. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.636 · Cited by 5,615
Levin, E. D., McClernon, F. J., & Rezvani, A. H. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0164-7 · Cited by 820
Event-related potential: An overview
Sur, S., & Sinha, V. (2009) · Industrial Psychiatry Journal · doi:10.4103/0972-6748.57865 · Cited by 656
Lieberman, J. A., Perkins, D., Belger, A., Chakos, M., Jarskog, F., Boteva, K., & Gilmore, J. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01303-8 · Cited by 593
Meta-analysis of the P300 and P50 waveforms in schizophrenia
BRAMON, E. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.01.004 · Cited by 569
Neurophysiological Endophenotypes of Schizophrenia: The Viability of Selected Candidate Measures
Turetsky, B. I., Calkins, M. E., Light, G. A., Olincy, A., Radant, A. D., & Swerdlow, N. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl060 · Cited by 567
Braff, D. L., Freedman, R., Schork, N. J., & Gottesman, I. I. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl049 · Cited by 455
Self-citationLeonard, S., Gault, J., Hopkins, J., Logel, J., Vianzon, R., Short, M., Drebing, C., Berger, R., Venn, D., Sirota, P., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.12.1085 · Cited by 441
Greenwood, T. A., Braff, D. L., Light, G. A., Cadenhead, K. S., Calkins, M. E., Dobie, D. J., Freedman, R., Green, M. F., Gur, R. E., Gur, R. C., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.11.1242 · Cited by 381
Self-citationSchizophrenia-Relevant Behavioral Testing in Rodent Models: A Uniquely Human Disorder?
Powell, C. M., & Miyakawa, T. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.008 · Cited by 366
P50 sensory gating ratios in schizophrenics and controls: A review and data analysis
Patterson, J. V., Hetrick, W. P., Boutros, N. N., Jin, Y., Sandman, C., Stern, H., Potkin, S., & Bunney, W. E. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.02.009 · Cited by 352
Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia
Martin, L., Kem, W., & Freedman, R. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1750-1 · Cited by 342
Neurophysiological biomarkers for drug development in schizophrenia
Javitt, D. C., Spencer, K. M., Thaker, G. K., Winterer, G., & Hajós, M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2463 · Cited by 342
Leonard, S., Adler, L. E., Benhammou, K., Berger, R., Breese, C. R., Drebing, C., Gault, J., Lee, M. J., Logel, J., Olincy, A., et al. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00677-3 · Cited by 300
Mouse genetic models for prepulse inhibition: an early review
Geyer, M. A., McIlwain, K. L., & Paylor, R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001159 · Cited by 285
Self-citationEttinger, U., Meyhöfer, I., Steffens, M., Wagner, M., & Koutsouleris, N. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00018 · Cited by 280
Schizophrenia: from phenomenology to neurobiology
Wong, A. H. C., & Van Tol, H. H. M. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00035-6 · Cited by 280
Hong, L. E., Summerfelt, A., Buchanan, R. W., O'Donnell, P., Thaker, G. K., Weiler, M. A., & Lahti, A. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.168 · Cited by 274
Review of Clinical Correlates of P50 Sensory Gating Abnormalities in Patients with Schizophrenia
Potter, D., Summerfelt, A., Gold, J., & Buchanan, R. W. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj050 · Cited by 259
Electroencephalography (EEG) and Event‐Related Potentials (ERPs) with Human Participants
Light, G. A., Williams, L. E., Minow, F., Sprock, J., Rissling, A., Sharp, R., Swerdlow, N. R., & Braff, D. L. (2010) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0625s52 · Cited by 258
Self-citationSchizophrenia and the α7 Nicotinic Acetylcholine Receptor
Martin, L. F., & Freedman, R. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78008-4 · Cited by 213
Glucocorticoid hormones and early brain development in schizophrenia
Ph.D., J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00396-7 · Cited by 199
“P50, are features commonly observed in schizophrenic patients (Flaum et al. 1995; Bilder et al. 1995; Freedman et al. 1997; Clementz et al. 1998; Velakoulis et al. 1999; Stefanis et al. 1999; Gur et al. 2000; Kupferberg and Heckers 2000; Walder et al. 2000).”
BackgroundAbnormal sleep spindles, memory consolidation, and schizophrenia
Manoach, D. S., & Stickgold, R. (2019) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050718-095754 · Cited by 157
Sensory gating endophenotype based on its neural oscillatory pattern and heritability estimate
Hong, L. E., Summerfelt, A., Mitchell, B. D., McMahon, R. P., Wonodi, I., Buchanan, R. W., & Thaker, G. K. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.9.1008 · Cited by 115
Braff, D. L., Light, G. A., & Swerdlow, N. R. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.015 · Cited by 90
Self-citationMeasuring P50 suppression and prepulse inhibition in a single recording session
Light, G. A., & Braff, D. L. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2066 · Cited by 59
Self-citationRein, B., Tan, T., Yang, F., Wang, W., Williams, J., Zhang, F., Mills, A., & Yan, Z. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0693-9 · Cited by 58
P50 sensory gating is related to performance on select tasks of cognitive inhibition
Yadon, C. A., Bugg, J. M., Kisley, M. A., & Davalos, D. B. (2009) · Cognitive, Affective, & Behavioral Neuroscience · doi:10.3758/cabn.9.4.448 · Cited by 43
Deficits in auditory P50 inhibition in obsessive-compulsive disorder
Hashimoto, T., Shimizu, E., Koike, K., Orita, Y., Suzuki, T., Kanahara, N., Matsuzawa, D., Fukami, G., Miyatake, R., Shinoda, N., et al. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.021 · Cited by 41
Metadata
- Authors
- Clementz, B. A., Geyer, M. A., & Braff, D. L.
- Venue
- American Journal of Psychiatry
- Published
- 1998-12-01
- Volume
- 155
- Issue
- 12
- Pages
- 1691-1694
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2005000985
- Cited by
- 276
- References
- 17
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.